Dina Alzadon
Gerontology · Henderson, NVNPI 1962982728
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (59.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Boston Scientific at 36.1% of the total. Reporting peaked in 2023 at $4,222 and has fallen 99.6% since, to $16 in 2025. Among gerontology clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $97.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$2K
- Acadia Pharmaceuticals Inc$660
- MDD US Operations, LLC$509
- AbbVie$245
- Neurocrine Biosciences, Inc.$233
- plus $282 from 4 others
What the payments were for
- Travel & lodging$3,68060%
- Food & beverage$2,44840%
- Education$451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $2,230 |
| Abbott | 12 | $2,013 |
| Acadia Pharmaceuticals Inc | 22 | $660 |
| MDD US Operations, LLC | 3 | $509 |
| AbbVie | 7 | $245 |
| Neurocrine Biosciences, Inc. | 4 | $233 |
| Teva Pharmaceuticals USA, Inc. | 4 | $198 |
| Medtronic | 1 | $45 |
| Acorda Therapeutics, Inc | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,173 in reported general payments places this provider in the 90th percentile of 72 gerontology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 73 | $359,465 |
| RytaryCarbidopa/Levodopa | 106 | $187,348 |
| AustedoDeutetrabenazine | 13 | $167,017 |
| IngrezzaValbenazine Tosylate | 20 | $162,447 |
| InbrijaLevodopa | 17 | $84,239 |
| GocovriAmantadine Hcl | 13 | $43,890 |
| NeuproRotigotine | 21 | $36,572 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 488 | $18,301 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 168 | $9,537 |
| OngentysOpicapone | 12 | $7,936 |
| AmantadineAmantadine Hcl | 93 | $6,699 |
| Rasagiline Mesylate | 38 | $6,404 |
| Entacapone | 22 | $5,946 |
| Primidone | 64 | $2,982 |
| Atropine Sulfate | 25 | $2,556 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $660 | $359,46573 claims |
| Neurocrine Biosciences, Inc.Ingrezza, Ongentys | $233 | $170,38232 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $198 | $167,01713 claims |
| Acorda Therapeutics, IncInbrija | $24 | $84,23917 claims |
| MDD US Operations, LLCGocovri | $509 | $43,89013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 72 gerontology providers in Nevada.
Other gerontology in Henderson
- Zarah GaerlanHenderson$11K
- Charynne QuinesaresHenderson$2K
- Mildred MartinezHenderson$710
- Leslie Hunter-JohnsonHenderson$383
- Sara McKnightHenderson$185
- Enzi AbebeLas Vegas$10K
- Jennifer GriffoReno$8K
- Jhouleen Angelika TiamzonLas Vegas$8K
- Elizabeth HasslerReno$7K
- Kelli NissenLas Vegas$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.